Optimization of an RNA isolation procedure from plasma samples

被引:1
作者
Cerkovnik, Petra
Perhavec, Andraz
Zgajnar, Janez
Novakovic, Srdjan
机构
[1] Inst Oncol Ljubljana, Dept Mol Diagnost, Ljubljana 1000, Slovenia
[2] Inst Oncol Ljubljana, Dept Surg Oncol, Ljubljana 1000, Slovenia
关键词
plasma RNA; RNA isolation; RNA integrity;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
In this study, we aimed to optimize the isolation procedure of circulating RNA from large volumes of plasma. Simultaneously, the stability and integrity of RNA from plasma samples were examined. To investigate the isolation of circulating RNA, reverse transcription-PCR analysis in combination with capillary electrophoresis was used. The presence of amplifiable RNA in plasma from healthy volunteers and from breast cancer patients was analyzed. We found that circulating RNA in plasma was highly fragmented and degraded. Plasma RNA was most efficiently isolated from large volumes of samples after introducing the step of plasma concentration by evaporation and by using TRIzol LS reagent. A single freeze/thaw process had no significant effect on RNA integrity and quantity of plasma RNA. The average amount of RNA in plasma from breast cancer patients was lower than in plasma from healthy volunteers. The concentrating of large volumes of plasma facilitates isolation of plasma RNA and yields amplifiable RNA for at least fragments that are up to 3 10 bp long.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 24 条
[1]
Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients [J].
Anker, P ;
Mulcahy, H ;
Chen, XQ ;
Stroun, M .
CANCER AND METASTASIS REVIEWS, 1999, 18 (01) :65-73
[2]
Chen XQ, 2000, CLIN CANCER RES, V6, P3823
[3]
Chen XQ, 1996, NAT MED, V2, P1033
[4]
Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA:: A simple blood test to monitor disease in cancer patients [J].
Dasí, F ;
Lledó, S ;
García-Granero, E ;
Ripoll, R ;
Marugán, M ;
Tormo, M ;
Garcia-Conde, J ;
Aliño, SF .
LABORATORY INVESTIGATION, 2001, 81 (05) :767-769
[5]
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics [J].
El-Hefnawy, T ;
Raja, S ;
Kelly, L ;
Bigbee, WL ;
Kirkwood, JM ;
Luketich, JD ;
Godfrey, TE .
CLINICAL CHEMISTRY, 2004, 50 (03) :564-573
[6]
Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias [J].
Goebel, G ;
Zitt, M ;
Zitt, M ;
Müller, HM .
DISEASE MARKERS, 2005, 21 (03) :105-120
[7]
Hasselmann DO, 2001, ONCOL REP, V8, P115
[8]
Hibi K, 1998, CANCER RES, V58, P1405
[9]
Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients [J].
Hickey, KP ;
Boyle, KP ;
Jepps, HM ;
Andrew, AC ;
Buxton, EJ ;
Burns, PA .
BRITISH JOURNAL OF CANCER, 1999, 80 (11) :1803-1808
[10]
Kopreski MS, 1999, CLIN CANCER RES, V5, P1961